| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | 2.16.840.1.113883.3.464.1003.1156 |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.464.1003.1156/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1156 |
| Version | 20211102 |
| Status | active |
| Date | 2021-11-02T01:01:44-04:00 |
| Name | SubstanceUseDisorderLongActingMedicationAdministration |
| Title | Substance Use Disorder Long Acting Medication Administration |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this Grouping value set is to represent concepts for long acting substance use disorder medication assisted treatment, usually administered as part of an opioid treatment program.),(Data Element Scope: This value set may use a model element related to Intervention.),(Inclusion Criteria: Includes interventions where a long acting substance use disorder treatment medication is administered (e.g., buprenorphine implant, buprenorphine injection or naltrexone injection).),(Exclusion Criteria: Excludes administration of short acting oral and sublingual substance use disorder treatment medication.) |
FHIR